Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity. 1996

P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
Center for Digestive Diseases, Medical and Veterinary Faculty, University of Zagreb, Croatia.

Very recently, the integrity of capsaicin somatosensory neurons and their protection were suggested to be related to the activity in nociception of a newly discovered 15-amino acid peptide, BPC 157, shown to have strong beneficial effect on intestinal and liver lesions. Therefore, from this viewpoint, we have studied the gastroprotective effect of the pentadecapeptide BPC 157, on gastric lesions produced in rats by 96% ethanol, restraint stress, and indomethacin. The possible involvement of sensory neurons in the salutary actions of BPC 157 (10 micrograms/kg, 10 ng/kg intraperitoneally) was studied with capsaicin, which has differential effects on sensory neurons: a high dose in adult (125 mg/kg subcutaneously, 3 months old) or administration (50 mg/kg subcutaneously) to neonatal animals (age of the 7 days) destroys sensory fibers, whereas a low dose (500 micrograms/kg intraperitoneally) activates neurotransmitter release and protective effects on the mucosa. In the absence of capsaicin, BPC 157 protected gastric mucosa against ethanol, restraint, and indomethacin application. In the presence of neurotoxic doses of capsaicin, the negative influence of capsaicin on restraint, ethanol, or indomethacin lesions consistently affected salutary activity of BPC 157. However, BPC 157 protection was still evident in the capsaicin-treated rats (either treated as adults or as newborns) in all of these assays. Interestingly, after neonatal capsaicin treatment, a complete abolition of BPC gastroprotection was noted if BPC 157 was applied as a single nanogram-regimen, but the mucosal protection was fully reversed when the same dose was used daily. In line with the excitatory dose of capsaicin the beneficial effectiveness of BPC 157 appears to be increased as well. Taken together, these data provide evidence for complex synergistic interaction between the beneficial effectiveness of BPC 157 and peptidergic sensory afferent neuron activity.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D009475 Neurons, Afferent Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM. Afferent Neurons,Afferent Neuron,Neuron, Afferent
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D012149 Restraint, Physical Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION. Immobilization, Physical,Physical Restraint,Physical Immobilization,Physical Restraints,Restraints, Physical
D002211 Capsaicin An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS. 8-Methyl-N-Vanillyl-6-Nonenamide,Antiphlogistine Rub A-535 Capsaicin,Axsain,Capsaicine,Capsicum Farmaya,Capsidol,Capsin,Capzasin,Gelcen,Katrum,NGX-4010,Zacin,Zostrix,8 Methyl N Vanillyl 6 Nonenamide,NGX 4010,NGX4010
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol

Related Publications

P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
December 1999, Journal of physiology, Paris,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
December 2016, European journal of pharmacology,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
January 2011, Current pharmaceutical design,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
January 2021, Frontiers in pharmacology,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
December 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
January 2012, Current medicinal chemistry,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
January 2013, Current pharmaceutical design,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
September 2004, European journal of pharmacology,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
January 2020, Drug design, development and therapy,
P Sikirić, and S Seiwerth, and Z Grabarević, and R Rucman, and M Petek, and V Jagić, and B Turković, and I Rotkvić, and S Mise, and I Zoricić, and M Gjurasin, and P Konjevoda, and J Separović, and D Ljubanović, and B Artuković, and M Bratulić, and M Tisljar, and L Jurina, and G Buljat, and P Miklić, and A Marović
December 2021, Biomedicines,
Copied contents to your clipboard!